Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer
Recruiting · NCT06654037 · Registry updated 2026-07-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Testing the Addition of an Anti-Cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (5-Fluorouracil) for Metastatic, Refractory Colorectal Cancer | Digestive System Diseases, Digestive System Neoplasms, Neoplasms by Site, colonic disorder, colorectal neoplasm, digestive system disorder, digestive system neoplasm, intestinal disorder, neoplasm, rectal disorder | Recruiting | Phase 1 | 2026-07-31 | NCT06654037 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| National Cancer Institute (NCI) | 3015 |
8 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Montefiore Medical Center - Moses Campus | The Bronx | United States | 219 |
| Montefiore Medical Center-Einstein Campus | The Bronx | United States | 170 |
| Montefiore Medical Center-Weiler Hospital | The Bronx | United States | 109 |
| UC Irvine Health/Chao Family Comprehensive Cancer Center | Orange | United States | 189 |
| UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care | Irvine | United States | 95 |
| University of Cincinnati Cancer Center-UC Medical Center | Cincinnati | United States | 143 |
| University of Cincinnati Cancer Center-West Chester | West Chester | United States | 122 |
| UPMC Hillman Cancer Center | Pittsburgh | United States | 330 |